MRI cortical feature of bulbar impairment in patients with amyotrophic lateral sclerosis by Donatelli, G et al.
Contents lists available at ScienceDirect
NeuroImage: Clinical
journal homepage: www.elsevier.com/locate/ynicl
MRI cortical feature of bulbar impairment in patients with amyotrophic
lateral sclerosis
Graziella Donatellia,b, Elena Caldarazzo Iencoc, Mauro Costaglia,d,⁎, Gianmichele Migaleddue,
Paolo Cecchib, Gabriele Sicilianoc, Mirco Cosottinib,e
a Imago7 Research Foundation, Pisa, Italy
b Neuroradiology Unit, Azienda Ospadaliero-Universitaria Pisana, Pisa, Italy
c Neurology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy
d Laboratory of Medical Physics and Magnetic Resonance, IRCCS Stella Maris, Pisa, Italy
e Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy
A B S T R A C T
The decline of voluntary bulbar functions such as speech and swallowing are among the clinical manifestations of amyotrophic lateral sclerosis (ALS) influencing a
worst prognosis. Differential diagnosis between the contribution of upper motor neuron (UMN) and lower motor neuron degeneration to the bulbar impairment is
often hard. Thinning and T2* hypointensity of the primary motor cortex have been recently suggested as possible MRI markers of UMN impairment in ALS patients,
but little research has purposely targeted the orofacial region of the primary motor cortex (fM1). With the aim of finding an MRI marker of UMN impairment
responsible for bulbar dysfunction, we investigated the T2* signal intensity of fM1 and the relationship with bulbar impairment in ALS patients. Fifty-five ALS
patients were examined with 3 T MRI. Their fM1 was evaluated both qualitatively in terms of T2* signal intensity and quantitatively by measuring its magnetic
susceptibility with Quantitative Susceptibility Mapping (QSM). Bulbar functions were assessed clinically, by neurological examination and using the items 1–3 of the
ALSFRS-R, and with neurophysiological tests.
The marked hypointensity of fM1 was detected in 25% of ALS patients, including all patients with bulbar onset, and was 74% sensitive, 100% specific and 91%
accurate in diagnosing functional bulbar impairment. Such hypointensity involved the middle and ventral part of fM1 and was usually visible in both hemispheres.
The magnetic susceptibility was significantly higher in patients with marked fM1 hypointensity than in the other patients (p≤ .001).
The relationship with clinical and neurophysiological data suggests that such feature could be a marker of UMN degeneration for voluntary bulbar functions.
1. Introduction
Amyotrophic lateral sclerosis (ALS) is a progressive and disabling
neurological disorder with a wide spectrum of clinical phenotypes
(Chiò et al., 2011; Kiernan et al., 2011). Pathological hallmarks of the
disease include the degeneration of both the upper (UMN) and lower
motor neurons (LMN). UMN pathology is reflected by the depopulation
of Betz cells in the primary motor cortex (M1) and the axonal loss in the
corticospinal tract (Kawamata et al., 1992; Wijesekera and Leigh,
2009), whereas the LMN degeneration is represented by the motor
neuron loss in the motor nuclei of the brainstem and in the anterior
horns of the spinal cord (Kawamata et al., 1992; Saberi et al., 2015).
Differently from the assessment of the LMN degeneration that can be
supported by electrophysiological tests (de Carvalho et al., 2008; Eisen
and Swash, 2001), the evaluation of the UMN impairment is currently
mainly clinical (Brooks et al., 2000; de Carvalho et al., 2008). Eliciting
UMN signs is difficult because of the disruption of the circuits involved
in their release and the co-existence of LMN muscle wasting (Swash,
2012). Several neurophysiological and MR techniques have been used
to assess signs of UMN degeneration in ALS patients (Huynh et al.,
2016), but none of them are currently recommended for diagnosing
UMN pathology (de Carvalho et al., 2008; Filippi et al., 2010).
The progressive disruption of bulbar functions reflected in speech
and swallowing is a frequent feature in ALS patients, heavily affecting
the quality of life and prognosis (Kiernan et al., 2011; Kühnlein et al.,
2008; Leigh et al., 2003). The site of disease onset in ALS is an im-
portant prognostic indicator: the overall median survival from symp-
toms onset is lower for bulbar onset cases (2–3 years) with respect to
limb onset cases (3–5 years) (Logroscino et al., 2008).
Bulbar impairment related to UMN degeneration reveals with
https://doi.org/10.1016/j.nicl.2019.101934
Received 20 November 2018; Received in revised form 8 July 2019; Accepted 13 July 2019
Abbreviations: ALS, amyotrophic lateral sclerosis; M1, primary motor cortex; fM1, orofacial region of the primary motor cortex; UMN, upper motor neuron; LMN,
lower motor neuron; fMRI, functional magnetic resonance imaging
⁎ Corresponding author at: Imago7 Research Foundation, Viale del Tirreno 331, 56128 Pisa, Italy.
E-mail address: mcostagli@imago7.eu (M. Costagli).
NeuroImage: Clinical 24 (2019) 101934
Available online 15 July 2019
2213-1582/ © 2019 Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license 
(http://creativecommons.org/licenses/BY-NC-ND/4.0/).
T
spastic dysarthria, tongue spasticity, brisk gag and jaw jerk reflexes,
palmomental reflex and pseudobulbar affect, whereas LMN degenera-
tion results in flaccid dysarthria, tongue wasting, weakness and fasci-
culation (Kiernan et al., 2011; Kühnlein et al., 2008). The detection of
signs related to UMN impairment in the bulbar region is anyway
challenging (Körner et al., 2011), due to the difficulty to disentangle the
selective relative contribution of UMN and LMN degeneration.
Recent MRI studies provided additional information to assess UMN
pathology, suggesting the thinning and the T2* hypointensity of M1 as
radiological markers of UMN impairment and neuroinflammation in
ALS patients (Cosottini et al., 2016; Donatelli et al., 2018; Vázquez-
Costa et al., 2018). Here, with the aim of finding an MRI marker of
UMN impairment responsible for bulbar dysfunction in ALS patients at
the single subject level, we (i) assessed the signal intensity in the or-
ofacial region of M1 (fM1) using a 3D T2*-weighted sequence at 3 T,
and (ii) investigated the relationship between fM1 signal intensity and
bulbar impairment.
2. Materials and methods
2.1. Patient cohort
We selected all patients with probable or definite diagnosis of ALS
(Brooks et al., 2000) clinically assessed in the Neurology Unit of the
Pisa University Hospital and who underwent 3 T-MRI examination of
the brain between December 2013 and December 2017. Patients with
concomitant psychiatric disorders and dementia or whose MR images
were heavily affected by artefacts were excluded. By following these
criteria, 55 patients were included in this study: 30 males and 25 fe-
males, age 62 ± 9 years (mean ± standard deviation).
Symptoms of bulbar impairment were evaluated at the time of the
MRI exam and in clinical follow-up using the items 1–3 of the ALS
Functional Rating Scale regarding speech, salivation and swallowing
(Cedarbaum et al., 1999) (ALSFRS-R bulbar score, range 0–12, with
lower scores reflecting greater disability). Signs of UMN impairment in
the bulbar region were clinically evaluated at the time of the MRI exam
by eliciting the palmomental reflex and assessing the pseudobulbar
affect. Electromyography (EMG) of the tongue, available for 18 pa-
tients, and motor evoked potentials obtained by fM1 transcranial
magnetic stimulation (TMS), available for two patients who had also
EMG, were analysed.
Disease Duration (DD, number of months from the ALS symptoms
onset to the MRI exam) and Disease Progression Rate (DPR), defined by
the formula DPR= (48−ALSFRS-R)/DD (Walhout et al., 2015), were
calculated. In patients with bulbar impairment at the time of the MRI
exam, Bulbar Disease Duration was also computed and defined as the
number of months from the bulbar symptom onset to the MRI exam. For
patients without bulbar impairment at the time of the MRI exam, data
of clinical follow-up were analysed and the possible eventual appear-
ance of bulbar impairment was recorded together with the time lag
from the MRI exam.
This study was approved by the local ethical committee; all parti-
cipants gave their written informed consent.
2.2. Image acquisition, post-processing and assessment
2.2.1. Standard imaging
All MRI exams of patients were performed using a 3 T system
(MR750 scanner, GE Healthcare, Chicago, IL) equipped with an 8-
channel head coil. The standard MRI protocol included one 3D T1-
weighted acquisition (Time of Repetition, TR=8.2ms; Time of Echo,
TE= 3.2ms; Inversion Time, TI= 450ms; Flip Angle, FA=12 deg.;
spatial resolution=1×1×1mm3, scan duration 4′33″) and
one 3D T2-weighted FLAIR sequence (TR=7000ms; TE=114.9ms;
TI= 1943ms; FA=90 deg.; spatial resolution of reconstructed
images= 0.5× 0.5× 0.6mm3, scan duration= 5′46″).
2.2.2. Qualitative imaging
In all patients, 3D multi-echo T2*-weighted images were acquired,
prescribed axially and targeting M1. Acquisition parameters were:
TR= 68.3ms; TE1:ΔTE:TE10= 13:5.6:63.7 ms; FA=15 deg.; spatial
resolution of reconstructed images= 0.39×0.39×1mm3; scan
duration= 4′22″.
This set of images was used for radiological assessment based on
visual inspection. Two experienced neuroradiologists, blinded to the
clinical features of patients, independently evaluated fM1, which was
defined on the basis of anatomical and radiological landmarks as the
region of M1 located ventrally to the hand knob and functionally
connected with the bulbar muscles (Penfield and Boldrey, 1937; Yousry
et al., 1997). The right and left fM1 of each subject were analysed se-
parately and along their entirety, and the T2* signal intensity of fM1
was graded after comparison to that of the postcentral cortex according
to the following scores: 0, similar signal intensity; 1, mildly hy-
pointense; 2, markedly hypointense (Fig. 1). For target regions where
there was disagreement between the neuroradiologists' individual
scores, a score reached in consensus was also given. In a following
reading session, one neuroradiologist assessed again the whole set of
T2*-weighted images to compute the intra-observer agreement.
2.2.3. Quantitative imaging
In 36 out of 55 patients another set of 3D multi-echo T2*-weighted
images was acquired with parameters tailored to produce quantitative
susceptibility maps (QSM). This sequence was prescribed axially and cov-
ered the brain from the vertex to the ponto-bulbar junction. Acquisition
parameters were: TR=68.1ms; TE1:ΔTE:TE16=13:3.4:64.4ms;
FA=15deg.; spatial resolution=0.94×0.94×1mm3; scan dura-
tion=8′44″. The magnitude and phase of the complex data underwent a
well-established post-processing pipeline (Costagli et al., 2016) that gen-
erated an average T2*-weighted 3D image and one quantitative magnetic
susceptibility (χ) map for each patient.
The set of χ maps was used to measure the magnetic susceptibility
in fM1. One neuroradiologist manually drew ROIs on χ maps, one ROI
for each fM1, in the location of the T2* hypointensity (score 1 and 2) or
in the deep layers of a putative segment of fM1 if no signal changes
were visible (score 0). The mean magnetic susceptibility in each ROI
was recorded.
2.2.4. Distribution of T2* hypointensity within the primary motor cortex
The distribution map of T2* hypointensity was superimposed to a
map of bulbar motor functions (a) to elucidate the distribution of mild
and marked T2* hypointensity (score 1 and 2, respectively) within fM1
and (b) to compare the distribution of marked T2* hypointensity within
the motor homunculus between patients with and without bulbar
symptoms.
One healthy volunteer underwent a high-resolution fMRI protocol
performed with a 7 T scanner (GE MR950) and including 2D Gradient-
Recalled Echo (GRE) Echo Planar Imaging (EPI) sequences and a 3D T1-
weighted acquisition. The fMRI acquisition consisted in a block-design
experiment with task periods of 4 s each alternated to rest periods of
16 s. The subject performed five tasks involved in the voluntary control
of motor bulbar functions consisting in lip pursing, vertical excursion of
the tongue, vocalisation, swallowing and contraction of masticatory
muscles. Four tasks consisting in the movement of the thumb and little
finger of both hands were performed to better delineate the motor
homunculus. For each task, areas of BOLD activation were super-
imposed on Montreal Neurological Institute (MNI) 152 standard space
(Mazziotta et al., 1995).
The 3D multi-echo T2*-weighted sequences used for visual image
analysis were also used to evaluate localisation and distribution of fM1
signal hypointensities. For each patient, one experienced neuroradiol-
ogists manually contoured these hypointensities onto the native T2*
images by creating a binary mask. (a) In order to elucidate the dis-
tribution of mild and marked T2* hypointensity within fM1, the right
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and left M1 of each subject were segmented and analysed separately.
Besides the areas of mild or marked fM1 hypointensity, also the areas of
marked T2* hypointensity in M1 subregions outside fM1 were seg-
mented. These masks were grouped for the side and the degree of hy-
pointensity and aligned to the MNI standard space. (b) To compare the
distribution of T2* hypointensity within the motor homunculus be-
tween patients with and without bulbar symptoms, the areas of marked
signal hypointensity were segmented along M1 entirety; the right and
left M1 of each subject were analysed together. These masks were
grouped based on the presence of bulbar symptoms and aligned to the
MNI standard space. In both analyses and for each group, masks were
summed to obtain a global localisation of fM1 hypointensities in our
patients to be compared with the functional map of bulbar motor tasks
obtained in the healthy subject.
Details of the MRI protocol and analysis are reported in online
supplementary appendix.
2.3. Statistical analysis
The ALSFRS-R bulbar score was used as gold standard to identify
subjects with bulbar functional impairment. For the qualitative ana-
lysis, patients who received score 2 in fM1 in at least one hemisphere
were considered as having definite signal alterations; all other patients
were considered as not having definite signal changes. Sensitivity,
specificity, positive predictive value, negative predictive value and di-
agnostic accuracy of the MR imaging were computed for each reader
and reading session, and for the consensus reading. The inter-observer
and intra-observer agreement for the qualitative image analysis were
calculated with the Cohen's kappa coefficient.
χ values of fM1 (two measurements for each patient) were grouped
based on the corresponding visual score, producing three different
groups of data (score 0, 1 and 2). These data were then analysed using a
linear mixed model with age and gender as covariates, and subject
identifier as grouping factor; p-values were computed using ANOVA.
In the subgroup of ALS patients without bulbar symptoms at the
time of the MRI exam, the Fisher's exact test was used to investigate the
association between the visual scores and the development of bulbar
impairment in the follow up time.
3. Results
3.1. Clinical data
Out of 55 patients, 19 had symptoms and 15 had also UMN signs of
bulbar impairment at the time of the MRI exam. The ALSFRS-R bulbar
score of the whole group of patients was 11 ± 1.7 (mean value±
standard deviation), whereas the ALSFRS-R bulbar score of the sub-
group of 19 patients with bulbar symptoms was 9.2 ± 1.7.
The time lag between the diagnosis and the MR exam was on




fM1 was rated as markedly hypointense in 14 out of 55 patients
(Fig. 2). All these 14 patients had symptoms of bulbar impairment at
the time of the MRI exam (ALSFRS-R bulbar score= 8.7 ± 1.7), and
all but one had also UMN signs of bulbar impairment (93%). In 12 of
these patients the score was 2 in both right and left side. In one case, the
hypointensity affected fM1 bilaterally and was associated with a
marked T2 FLAIR hyperintensity confined in the location of both cor-
ticobulbar tracts, without signal changes in the other sub-regions of M1
and in the corticospinal tract (Fig. 3).
fM1 was rated as mildly hypointense in 10 patients (score 1); in 7 of
these patients the score was 1 in both right and left side (Fig. 2). Only 1
patient of this group had bulbar symptoms (ALSFRS-R bulbar
score= 10), and two patients without bulbar symptoms had the pal-
momental reflex or the pseudobulbar affect.
Fig. 1. T2*-weighted images of the primary motor cortex at the level of fM1
(arrows) in three ALS patients. The T2* signal intensity of the deeper layers of
fM1 was classified as having score 0 if it was similar to that of the post-central
cortex (A), score 1 if it was mildly reduced (B), and score 2 if it was markedly
reduced (C).
ALS, amyotrophic lateral sclerosis; fM1, orofacial region of the primary motor
cortex.
Table 1
Epidemiological and clinical data of ALS patients.
ALS patients n=55
Gender (male/female) n=30 / 25
Agea 62 ± 9 yrs
Onset n (%)
Bulbar 11 (20%)
Upper limbs 15 (27%)
Lower limbs 29 (53%)
ALSFRS-Ra 41 ± 4.4
ALSFRS-R bulbar scorea
In the whole group of ALS patients 11 ± 1.7
In the sub-group of ALS patients with bulbar symptoms
(n=19)
9.2 ± 1.7
Patients with bulbar UMN signs n=21
Disease duration (months)a 13.8 ± 10.3
Disease progression ratea 0.7 ± 0.7
ALS, amyotrophic lateral sclerosis; ALSFRS-R, ALS Functional Rating Scale
Revised; UMN, upper motor neuron.
a expressed as mean ± standard deviation.
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In the remaining 31 patients, fM1 received score 0 in both hemi-
spheres (Fig. 2); among them, 4 patients had bulbar symptoms
(ALSFRS-R bulbar score≥ 10) and 6 patients had the palmomental
reflex or the pseudobulbar affect.
At visual image assessment, sensitivity, specificity, positive pre-
dictive value, negative predictive value and diagnostic accuracy of the
marked T2* hypointensity in fM1 (score 2) in identifying patients with
symptoms of bulbar impairment were respectively 0.74, 1, 1, 0.88 and
0.91 at the consensus reading; all other results are reported in Table 2.
The intra-observer and inter-observer agreement were 0.95 and 0.76,
respectively.
All patients with bulbar onset had marked fM1 hypointensity.
Among patients with symptoms of bulbar impairment at the time of
the MRI exam, those with score 0 or 1 in fM1 had a mean Bulbar
Disease Duration of 2months (range 1–4months); in patients with
marked fM1 hypointensity (score 2), instead, the mean Bulbar Disease
Duration was 9months (range 2–17months), with 5 patients (36%)
having bulbar symptoms since<6months.
3.2.2. Quantitative imaging
χ was significantly different among fM1 with different visual scores
(p < .0001) (Fig. 4); the highest values were observed in the group
with score 2 (0.080 ± 0.021 ppm in fM1 with score 2;
Fig. 2. The heat map represents the hypointensity scores recorded in the consensus reading in the right and left fM1 of every subject. Each column represents data of
one patient, sorted on the basis of the ALSFRS-R bulbar score shown on the top of the figure. The red line divides patients with bulbar symptoms at the time of the
MRI exam (ALSFRS-R bulbar score < 12, on the left) from patients without bulbar symptoms (on the right).
ALS, amyotrophic lateral sclerosis; fM1, orofacial region of the primary motor cortex.
Fig. 3. Axial T2*-weighted images of the primary motor cortex (A and B) and a coronal T2 FLAIR image at the level of the corticospinal tract (C) of an ALS patient
with bulbar impairment. In both hemispheres, the deep layers of the orofacial region of the primary motor cortex appear hypointense (A, arrows) and the white
matter in the location of the corticobulbar bundle is hyperintense in the T2 FLAIR image (C, arrows). On the contrary, the primary motor cortex corresponding to the
functional areas of limbs (B, outlined arrows) are neither thin nor hypointense compared to the post-central cortex and the white matter in the location of the
corticospinal tract is not hyperintense (C, outlined arrows). The representation of the motor homunculus in C has been modified from Penfield and Rasmussen, 1950.
Table 2











Sensitivity 0.68 0.63 0.74 0.74
Specificity 1 0.94 1 1
PPV 1 0.86 1 1
NPV 0.86 0.83 0.88 0.88
Diagnostic
accuracy
0.89 0.84 0.91 0.91
ALS, amyotrophic lateral sclerosis; PPV, positive predictive value; NPV, nega-
tive predictive value.
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0.062 ± 0.014 ppm in fM1 with score 1; 0.047 ± 0.012 ppm in fM1
with score 0).
3.2.3. Distribution of T2* hypointensity within the primary motor cortex
Twenty-four out of 55 patients had mild or marked hypointensity in
fM1 (score 1 and 2, respectively). The localisation of signal changes
along fM1 was different in patients with mild hypointensity compared
to patients with marked hypointensity. In patients with score 2, the
hypointensity was visible as a thin and demarcated stripe which in-
volved the deep layers of fM1 closer to the Sylvian fissure; this region
corresponds to the cortical areas functionally related with speech,
mastication and swallowing (Fig. 5A and C). On the contrary, in pa-
tients with mild fM1 hypointensity, the signal alteration was usually
pale and close to the hand knob, without a significant involvement of
the more ventral cortical areas related to the main bulbar functions
(Fig. 5B and C).
Differently from the group of patients with bulbar symptoms, where
the marked T2* hypointensity extensively involved fM1, in patients
without bulbar symptoms the marked T2* hypointensity was located in
the dorsal part of M1 without extending to fM1 (Fig. 6).
3.3. Neurophysiological findings in ALS patients with marked fM1
hypointensity
In the sub-group of 14 patients with bulbar symptoms and marked
fM1 hypointensity, 5 patients had noteworthy neurophysiological data.
Two patients underwent both EMG of tongue and TMS of fM1: in one
patient they revealed a mild prolongation of the central motor con-
duction time with no signs of acute or chronic denervation, while in the
other patient fasciculation potentials in the genioglossus muscle mat-
ched with a slightly abnormal central motor conduction time referred to
the left side tongue. In the latter patient, the T2* hypointensity was
more pronounced in the right fM1 than in the left one (Fig. 7).
In the other three patients who got only EMG of the tongue, no signs
of denervation were recorded.
3.4. Clinical follow-up of ALS patients without bulbar impairment at the
time of the MRI examination
Among patients with mild fM1 hypointensity (score 1, n=9), 3
patients (33%) developed symptoms of bulbar impairment at a later
time, whereas the remaining patients were still asymptomatic after a
mean follow-up of 11months (range 4–29).
Among patients with normal appearance of fM1 (score 0, n=27), 6
patients (22%) developed bulbar symptoms at a later time, whereas 17
patients were still asymptomatic after a mean follow-up of 13 months
(range 1–45). Clinical follow-up data of 4 patients were not available.
Among patients who had developed bulbar symptoms after the MRI
exam, the percentage of patients with score 1 did not differ from that of
patients with score 0 (p= .69).
4. Discussion
This study focused on assessing the T2* hypointensity of the deep
layers of fM1 in ALS patients with bulbar impairment and on in-
vestigating the meaning of this signal alteration in light of clinical data.
The search for a non-invasive and reliable neuroimaging marker of
UMN pathology in ALS patients has received renewed attention in the
recent years with the advent of Ultra High Magnetic Field MR. Among
MR tools, the T2* hypointensity of M1 has raised interest and has been
suggested as a marker of UMN degeneration and neuroinflammation
rather than a distinctive feature of all ALS patients (Cosottini et al.,
2016; Vázquez-Costa et al., 2018). Such signal alteration occurs in the
deeper layers of M1 (Cosottini et al., 2016), likely including the ana-
tomical location of the Betz cells; it corresponds to paramagnetic tissue
(Costagli et al., 2016) and co-localises with activated iron-loaded mi-
croglia (Kwan et al., 2012); moreover, magnetic susceptibility changes
in the cortex correspond to the degree of microglial activation
(Pallebage-Gamarallage et al., 2018).
The clinical UMN burden can differ from one body region to another
(Körner et al., 2011) and the magnitude of hypointensity along M1
might be not uniform in the same patient (Vázquez-Costa et al., 2018).
Because of the significant correlation between clinical UMN impair-
ment of the limbs and T2* hypointensity of the corresponding regions
of M1 (Cosottini et al., 2016), the cortical hypointensity can be a tool to
assess the UMN degeneration in each region of the motor homunculus.
In particular, it could be useful to detect the cortical involvement in
orofacial symptoms of ALS patients, a topic that has not been com-
pletely elucidated.
Previous pathologic reports in ALS patients with bulbar involvement
showed alterations in the motor nuclei of the lower cranial nerves,
mainly in the hypoglossal nucleus (Brownell et al., 1970; Lawyer and
Netsky, 1953). Besides this evidence of LMN pathology, a few patients
suffering from motor neuron disease with bulbar signs and pyramidal
tract degeneration but in the absence of motor cells loss in the hy-
poglossal nuclei were also described (Brownell et al., 1970), supporting
the hypothesis that bulbar impairment can be related, at least in part, to
UMN pathology.
In this scenario, we showed that in some patients the cortical hy-
pointensity is detectable also in the orofacial region of the motor ho-
munculus and that such radiological sign is related to the bulbar dis-
ability caused by UMN pathology. Indeed, the marked fM1
hypointensity (score 2) was located in the region of M1 functionally
related with mastication, swallowing and phonation, and it can serve as
an UMN sign of bulbar impairment. The T2* hypointensity corre-
sponded to paramagnetic tissue, further supporting the hypothesis of
cortical neuroinflammation associated with UMN impairment (Kwan
et al., 2012).
In ALS patients, the relationship between the amount of T2* hy-
pointensity or magnetic susceptibility of M1 and the clinical UMN
burden of the corresponding body regions has been previously de-
monstrated for the limb impairment (Cosottini et al., 2015; Costagli
Fig. 4. Boxplot of magnetic susceptibility values recorded in fM1 of ALS pa-
tients. Data were grouped on the basis of the corresponding visual score; mean
values and standard deviation are represented. * p= .01; ** p= .001; ***
p < .0001.
ALS, amyotrophic lateral sclerosis; fM1, orofacial region of the primary motor
cortex.
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Fig. 5. Localisation of fM1 signal hypointensities of ALS patients on the functional map of bulbar motor tasks. Anatomical localisation of the marked (score 2; A, red)
and mild (score 1; B, blue) fM1 hypointensities depicted in oblique coronal images at the level of the precentral gyrus and in three dimensional views. Patients were
grouped according to the degree of hypointensity in fM1. In B the most ventral and focal area of mild hypointensity in the left hemisphere refers to two patients: the
first had bulbar symptoms and marked hypointensity in the contralateral fM1; the second had unilateral focal area of mild hypointensity without bulbar impairment.
Distribution of mild and marked fM1 hypointensities on the functional map of bulbar motor tasks (C). Compared to patients with mild fM1 hypointensity, in patients
with marked hypointensity the signal change extended more ventrally, approaching the Sylvian fissure, and involved the region of the primary motor cortex
corresponding to the functional areas of speech, mastication and swallowing. Using selective motor tasks, different areas of activation were revealed along fM1 which
reflect the somatotopy described by Penfield and Boldrey, 1937. In the dorsoventral direction, the functional motor area of the hand is followed by those of lips,
tongue, vocalisation, masticatory muscles and swallowing. (For interpretation of the references to color in this figure legend, the reader is referred to the web version
of this article.)
ALS, amyotrophic lateral sclerosis; fM1, orofacial region of the primary motor cortex.
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et al., 2016) but has never been explored for the bulbar dysfunction.
The organisation of fM1 and the detection of signs and symptoms of
UMN impairment in the bulbar region have some peculiarities that
make this investigation very hard. Indeed, although the ALSFRS-R score
does not clearly distinguish the individual contribution of the two
motor neuron compartments to symptoms, it probably reflects largely
the functional impairment related to LMN rather than UMN degenera-
tion (Bede and Hardiman, 2014; Sorarù et al., 2010). Moreover, the
cortical representation of voluntary bulbar motor functions is located in
fM1 of both hemispheres even though with a contralateral prevalence
(Cattaneo and Pavesi, 2014), and the identification of the side affected
or more affected based on clinical signs or symptoms is very challen-
ging.
Among patients with mild fM1 hypointensity (score 1), in only two
cases the signal change was visible along fM1 more ventrally than
usual. The first patient had bulbar symptoms and marked hypointensity
on the contralateral fM1. The second patient, instead, had a focal and
unilateral mild hypointensity without symptoms of bulbar impairment;
this patient still did not present bulbar symptoms after 6months follow-
up, and the further clinical follow-up might provide additional in-
formation to speculate about a prognostic role of this radiological sign
in anticipating the clinical bulbar impairment.
From a clinical standpoint, signs related to LMN impairment of or-
ofacial muscles are more frequently reported than those suggestive of
UMN dysfunction (Körner et al., 2011; Zoccolella et al., 2006) also in
patients with bulbar onset (Körner et al., 2011). With our method, we
recorded a high incidence (74%) of cortical signal changes suggestive of
UMN degeneration in patients with bulbar symptoms, thus supposing
an underestimation of the reported data probably because of the diffi-
culty in detecting bulbar UMN signs in the clinical examination (Körner
et al., 2011).
Besides patients with clinical, neurophysiological and MRI data
suggestive of bulbar dysfunction related to UMN degeneration, in our
cohort there were also (i) patients with bulbar symptoms in the absence
of marked fM1 hypointensity, and (ii) patients with a mild and pale fM1
hypointensity who had no symptoms of bulbar impairment. Some
considerations can help in interpreting these results.
(i) As mentioned above, the ALSFRS-R assesses the functional im-
pairment and is likely affected by LMN dysfunction (Bede and
Hardiman, 2014; Sorarù et al., 2010). Therefore, in some cases, the
bulbar impairment revealed with the ALSFRS-R can be mainly
Fig. 6. Distribution of the marked T2* hypointensity of M1 in patients with and without bulbar symptoms (panels A and B, respectively), and map of bulbar functions
(C). In the group of patients with bulbar symptoms (A) the marked T2* hypointensity extensively involved M1, including the most ventral part of fM1 that is the brain
region in charge of the main bulbar motor functions (C). On the contrary, in patients without bulbar symptoms (B) the marked T2* hypointensity did not extend to
fM1 and was visible only in the dorsal part of M1, which represents the voluntary muscles of the limbs. The red and blue outlines in C indicate the extent of marked
T2* hypointensity in patients with and without bulbar symptoms, respectively. (For interpretation of the references to color in this figure legend, the reader is
referred to the web version of this article.)
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related to LMN pathology. Another issue is that MRI might not be
able to detect the UMN pathology underlying light clinical im-
pairment (Donatelli et al., 2018) and oncoming symptoms. In our
study, indeed, patients with bulbar symptoms and mild or no T2*
hypointensity had shorter Bulbar Disease Duration and greater
ALSFRS-R bulbar score than patients with bulbar symptoms and
marked T2* hypointensity in fM1. Moreover, the presence of the
palmomental reflex or the pseudobulbar affect in 2 patients with
bulbar symptoms and without marked fM1 hypointensity might
further support the latter hypothesis, even though the ratio of pa-
tients with these features is similar to the reported prevalence of the
palmomental reflex in the healthy population (Schott and Rossor,
2016).
(ii) In our cohort of patients, the marked hypointensity was present
only in patients with bulbar symptoms, whereas the mild hy-
pointensity in the most dorsal part of fM1 was usually visible in
patients without bulbar disability. Therefore, we suppose that the
mild hypointensity is a physiological appearance of fM1 in some
patients rather than a radiological sign of UMN degeneration.
However, other interpretations cannot be definitely ruled out. (a)
The items 1–3 of the ALSFRS-R investigate complex bulbar func-
tions whose effectors are functionally located in the middle and
ventral part of fM1; patients with marked fM1 hypointensity ex-
hibited MR signal change specifically in this region. On the con-
trary, the mild hypointensity is usually pale, focal and located in
the dorsal segment of fM1, where the functional representation of
mimic muscles of the upper face is expected, with a negligible in-
volvement of the brain region in charge of the main bulbar motor
functions; therefore, the mild hypointensity might be related to
UMN dysfunction of mimic muscle. (b) Alternatively, since UMN
pathology and dysfunction have been reported also in patients
without clinical evidence of UMN impairment or some months
Fig. 7. Example of one ALS patient with bulbar impairment. In A and B, T2*-weighted images showed an asymmetry in the degree of hypointensity, being more
marked in the right fM1 (arrow) than in the left fM1 (outlined arrow). Motor evoked potentials from tongue muscles (C: left, D: right). The coil was placed over the
contralateral hemisphere, 4 cm from the vertex, and then at the mandible jaw to record respectively the total motor conduction time (TMCT=T1) and the direct
peripheral motor conduction time (PMCT=T2). For each patient, the recording has been performed consecutively from both right and left tongue muscles by
stimulating the contralateral motor cortex. Central motor conduction time (CMCT=T3) was then calculated by subtracting latencies obtained after nerve root
stimulation from those after central stimulation (T3=TMCT – PMCT). Increased TMCT and CMCT were recorded from left tongue muscle, reflecting the impairment
of corticomotoneuronal connections.
ALS, amyotrophic lateral sclerosis; fM1, orofacial region of the primary motor cortex.
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before symptoms onset (Tsuchiya et al., 2002; Urban et al., 1998;
Vucic et al., 2008), the mild hypointensity might be a pre-symp-
tomatic marker of UMN-related bulbar impairment. The presence of
the palmomental reflex or the pseudobulbar affect in two patients
with mild fM1 hypointensity who had not bulbar symptoms might
support the latter hypothesis; however, the small number of pa-
tients does not allow to draw conclusions.
In our patient group, other two situations deserve to be discussed.
First, 4 patients with a normal radiological appearance of fM1 and
without bulbar symptoms had palmomental reflex, which reflects the
involvement of corticobulbar fibres. A recent work showed that this
reflex is associated and possibly predictive of UMN signs in bulbar re-
gion (Arwas et al., 2018), however other studies observed that it is not
specific for UMN dysfunction in ALS, as it was reported in many and
diverse conditions including Alzheimer's disease, cerebrovascular dis-
ease, Down's syndrome, mass lesions and hydrocephalus (Schott and
Rossor, 2016). The absence of bulbar symptoms and the lack of speci-
ficity of that reflex did not allow to recognise these cases as radiological
misdiagnosis. Second, one patient with marked and bilateral fM1 hy-
pointensity who reported slight bulbar symptoms did not show UMN
signs of bulbar impairment. This situation represents the classical case
where MRI could provide useful information in assessing the bulbar
UMN burden in ALS patients.
Only a few MRI studies investigated the fM1 appearance in ALS
patients. Using voxel-based morphometry or cortical thickness mea-
sures, some authors showed bilateral fM1 atrophy in patients with
bulbar onset (Bede et al., 2013; Schuster et al., 2013) and bulbar UMN
signs (Schuster et al., 2013), and association between fM1 atrophy and
ALSFRS-R bulbar score (Bede et al., 2013; Walhout et al., 2015). Dif-
ferently from these studies, we investigated a simple radiological sign,
namely the T2* hypointensity of M1, which is easily and rapidly as-
sessable at the single subject level using 3 T-MR systems, therefore
readily implementable in the clinical routine. Based on our results, we
propose this sign as an imaging marker of UMN degeneration also for
bulbar motor functions. Therefore, because of its high sensitivity in
detecting cortical hypointensity (Adachi et al., 2015; Cosottini et al.,
2016), 3D multi-echo T2*-weighted sequences could become a useful
tool to support the clinical evaluation of ALS patients and detect UMN
contribution to bulbar symptoms; moreover, this sign might contribute
to diagnose the ALS bulbar phenotype, with a possible prognostic value
(Chiò et al., 2011).
The main limitation of this study is the use of ALSFRS-R as gold
standard for assessing bulbar impairment in lack of extensive neuro-
physiological data and clinical signs of UMN impairment. The clinical
evaluation of bulbar functions is mainly based on subjective feeling of
disability. We used the presence of palmomental reflex and pseudo-
bulbar affect as signs of UMN impairment in the bulbar region, al-
though they are not invariably specific for UMN degeneration. Indeed,
they were reported in some other neurological conditions, also without
clear involvement of the motor pyramidal tract (Ahmed and Simmons,
2013; Schott and Rossor, 2016), and in some healthy people, while
their absence in disease states has also been described (Owen and
Mulley, 2002). Coexisting neurophysiological alterations are usually
not systematically explored whenever the diagnosis becomes defined,
being the investigation methods uncomfortable and often not well tol-
erated by patients. Nonetheless, the availability of a complete set of
clinical and neurophysiological data referred to bulbar muscles at
baseline and in the follow-up could further support our results and
provide additional information to investigate the role of T2*-weighted
images in the pre-symptomatic stage of bulbar dysfunction.
5. Conclusion
This study showed that, using a 3 T-MR system, the marked and thin
T2* hypointensity in fM1 is a frequent and easily detectable feature in
ALS patients with bulbar impairment. This signal alteration involves the
middle and ventral part of fM1 and is usually visible in both hemi-
spheres.
The relationship between imaging, clinical and neurophysiological
data suggests the marked hypointensity of fM1 as a marker of UMN
degeneration responsible for the impairment of voluntary bulbar motor
functions.
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